Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 220,856,454 papers from all fields of science
Search
Sign In
Create Free Account
BP 554
Known as:
BP-554
, Piperazine, 1-(3-(1,3-benzodioxol-5-yloxy)propyl)-4-phenyl-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Piperazines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Gonadectomy changes the pituitary-adrenocortical response in mice to 5-HT1A receptor agonists.
T. Matsuda
,
Y. Nakano
,
T. Kanda
,
H. Iwata
,
A. Baba
European Journal of Pharmacology
1991
Corpus ID: 4618383
The effects of 5-HT1A receptor agonists such as 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), BP-554 and buspirone on the…
Expand
1990
1990
p-chlorophenylalanine attenuates the pituitary-adrenocortical response to 5-HT1A receptor agonists in mice.
T. Matsuda
,
T. Kanda
,
Y. Seong
,
A. Baba
,
H. Iwata
European Journal of Pharmacology
1990
Corpus ID: 4551516
1990
1990
5-Hydroxytryptamine modulation of electrically induced twitch responses of mouse vas deferens: involvement of multiple 5-hydroxytryptamine receptors.
Y. Seong
,
A. Baba
,
T. Matsuda
,
H. Iwata
Journal of Pharmacology and Experimental…
1990
Corpus ID: 24510063
The actions of 5-hydroxytryptamine (5-HT) on the electrically induced twitch responses of mouse vas deferens were studied. 5-HT…
Expand
1990
1990
AGONIST ACTIVITY OF A NOVEL COMPOUND, BP-554,AT CENTRAL SEROTONIN-1A RECEPTORS
T. Matsuda
,
Y. Seong
,
+5 authors
A. Tobe
1990
Corpus ID: 82600375
1989
1989
Agonist activity of a novel compound, 1-[3-(3,4-methylenedioxyphenoxy)propyl]-4-phenyl piperazine (BP-554), at central 5-HT1A receptors.
T. Matsuda
,
Y. Seong
,
+5 authors
H. Iwata
European Journal of Pharmacology
1989
Corpus ID: 4613755
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE